PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 5/20

PharmD_KS's avatar
PharmD_KS
May 19, 2026
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 5/17

Today sellers were able to take out last week’s low. The weekly plan included some extended scenario analysis to aid us in determining if this is a bear trap or if bearish continuation is likely. We have NVDA earnings after the bell and it seems like every NVDA 0.00%↑ earnings day for the last 3 years has been ultra trappy so bias will need to remain in check until we have resolution. Tonight’s plan builds on some of the scenario analysis from the weekly plan to help us to identify which side is being trapped tomorrow.

For today, once again money was available to be made on both sides. Our short setup happened to play out first, but there were plenty of longs to be had as well. I liked the short on NQ better than the short on ES personally:

After the early overnight look above and fail (LAAF) of 29114-29135 it was resistance all day.

Last week’s low (28742 down there) was taken out, and we see that sellers covered quite a bit before leaning back in at 29114-29135.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture